This information is intended only for healthcare professionals resident in the United Kingdom
Prescribing Information (PI) for Trazimera® (trastuzumab)
Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed
Trazimera (trastuzumab) 150mg Powder for Concentrate for Solution for Infusion - PI for UK
Trazimera (trastuzumab) 420mg Powder for Concentrate for Solution for Infusion - PI for UK
PP-TAS-GBR-0064 January 2025